Medartis Holding AG
Medartis Holding AG, a medical device company, engages in the development, manufacturing, and sales of implant solutions worldwide. The company's medical devices are used for the treatment of surgical fixation of bone fractures for upper and lower extremities, as well as for the cranio-maxillofacial surgery. It provides osteosynthesis products for the hand, wrist, forearm, elbow, shoulder, and fo… Read more
Medartis Holding AG (MDRSF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.033x
Based on the latest financial reports, Medartis Holding AG (MDRSF) has a cash flow conversion efficiency ratio of 0.033x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($8.64 Million) by net assets ($261.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medartis Holding AG - Cash Flow Conversion Efficiency Trend (2014–2024)
This chart illustrates how Medartis Holding AG's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medartis Holding AG Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medartis Holding AG ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Hanmi Financial Corporation
NASDAQ:HAFC
|
0.184x |
|
Ratos AB (publ)
PINK:RTOBF
|
0.063x |
|
Taiflex Scientific Co Ltd
TW:8039
|
0.090x |
|
Abcellera Biologics Inc
NASDAQ:ABCL
|
-0.030x |
|
Aecon Group Inc
PINK:AEGXF
|
0.209x |
|
WHA Premium Growth Freehold And Leasehold Real Estate Investment Trust
BK:WHART
|
-0.001x |
|
LegalZoom.com Inc
NASDAQ:LZ
|
0.199x |
|
Cartesian Growth Corporation II Warrant
NASDAQ:RENEW
|
-0.002x |
Annual Cash Flow Conversion Efficiency for Medartis Holding AG (2014–2024)
The table below shows the annual cash flow conversion efficiency of Medartis Holding AG from 2014 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $269.65 Million | $32.07 Million | 0.119x | +51.78% |
| 2023-12-31 | $254.96 Million | $19.98 Million | 0.078x | +574.45% |
| 2022-12-31 | $237.78 Million | $-3.93 Million | -0.017x | -117.66% |
| 2021-12-31 | $224.00 Million | $20.95 Million | 0.094x | +58.02% |
| 2020-12-31 | $213.04 Million | $12.61 Million | 0.059x | +57.27% |
| 2019-12-31 | $215.57 Million | $8.11 Million | 0.038x | +27.36% |
| 2018-12-31 | $218.23 Million | $6.45 Million | 0.030x | -95.43% |
| 2017-12-31 | $17.04 Million | $11.01 Million | 0.646x | -7.16% |
| 2016-12-31 | $17.10 Million | $11.91 Million | 0.696x | +375.23% |
| 2015-12-31 | $-46.95 Million | $11.88 Million | -0.253x | -1488.30% |
| 2014-12-31 | $-54.26 Million | $-988.65K | 0.018x | -- |